Treatment of Refractory Prurigo Nodularis with a Monoclonal Antibody Dupilumab with Surprising Clinical Response

Indian J Dermatol. 2023 Jan-Feb;68(1):102-103. doi: 10.4103/ijd.ijd_746_22.
No abstract available